targeting plasmodium pik eliminate malaria 
achieving goal malaria elimination will depend targeting plasmodium pathways essential across life stages identify lipid kinase phosphatidylinositol--oh kinase pik target imidazopyrazines new antimalarial compound class inhibits intracellular development multiple plasmodium species stage infection vertebrate host imidazopyrazines demonstrate potent preventive therapeutic transmission-blocking activity rodent malaria models active blood-stage field isolates major human pathogens p falciparum p vivax inhibit liver-stage hypnozoites simian parasite p cynomolgi show imidazopyrazines exert effect inhibitory interaction atp-binding pocket pik altering intracellular distribution phosphatidylinositol--phosphate collectively data define pik key plasmodium vulnerability opening new avenues target-based discovery identify drugs ideal activity profile prevention treatment elimination malaria 
